Salt - Friend or foe?

Nephrology Dialysis Transplantation

Volumn 21, Issue 8, 2006, Pages 2052-2056

  Ritz, Eberhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Hypertension; Oxidative stress; Progression; Renal disease; Salt; Sodium

Indexed keywords

8 ISOPROSTANE; ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE;

ALBUMINURIA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; EVIDENCE BASED MEDICINE; HEALTH PROMOTION; HISTORY OF MEDICINE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; KIDNEY INJURY; META ANALYSIS; NONHUMAN; NOTE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POTASSIUM INTAKE; PRIORITY JOURNAL; RELIGION; RISK BENEFIT ANALYSIS; SALT INTAKE; SALT LOADING; SOCIOECONOMICS; SODIUM APPETITE; SODIUM BALANCE; SODIUM METABOLISM; SODIUM RESTRICTION; STROKE;

ANIMALS; ANIMALS, DOMESTIC; ANIMALS, WILD; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; DEFICIENCY DISEASES; DIET, SODIUM-RESTRICTED; FEMALE; FOOD PREFERENCES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; KIDNEY; MALE; MICE; MORTALITY; NITRIC OXIDE SYNTHASE TYPE III; NUTRITIONAL REQUIREMENTS; OXIDATIVE STRESS; PAN TROGLODYTES; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, INBRED SHR; RATS, WISTAR; RENIN-ANGIOTENSIN SYSTEM; SODIUM CHLORIDE, DIETARY;

EID: 33748060511     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi256     Document Type: Note

References (42)

1. Bergier J-F. Une Histoire du Sel. Office du livre S.A., Fribourg, Switzerland; 1982
2. Hocquet J-C. Le Sel et le Pouvoir. Editions Albin Michel S.A, Paris; 1985
3. Kurlansky M. Salt - A World History. Jonathan Cape, London; 2002
4. Ritz E. The history of salt - aspects of interest to the nephrologist. Nephrol Dial Transplant 1996; 11: 969-975
5. MacGregor GA, de Wardener HE. Neprune's Poisoned Chalice: Salt, Diet and Health. Cambridge University Press; 1998
6. Denton D, Weisinger R, Mundy NI et al. The effect of increased salt intake on blood pressure of chimpanzees. Nature Med 1995; 1: 1009-1016
7. Forte JG, Miguel JM, Miguel MJ, de Padua F, Rose G. Salt and blood pressure: A community trial. J Hum Hypertens 1989; 3: 179-184
8. Geleijnse JM, Hofman A, Witteman JC, Hazebroek AA, Valkenburg HA, Grobbee DE. Long-term effects of neonatal sodium restriction on blood pressure. Hypertension 1997; 29: 913-917
9. Sacks FM, Svetkey LP, Vollmer WM et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3-10
10. He FJ, MacGregor GA. How far should salt intake be reduced?. Hypertension 2003; 42: 1093-1099
11. Charra B, Bergstrom J, Scribner BH. Blood pressure control in dialysis patients: Importance of the lag phenomenon. Am J Kidney Dis 1998; 32: 720-724
12. Titze J, Bauer K, Schafflhuber M et al. Internal sodium balance in DOCA-salt rats: A body composition study. Am J Physiol 2005; 289: F793-F802
13. Sato K, Kihara M, Hashimoto T et al. Alterations in renal endothelial nitric oxide synthase expression by salt diet in angiotensin type-1a receptor gene knockout mice. J Am Soc Nephrol 2004; 15: 1756-1763
14. Sowers JR. Hypertension, angiotensin II, and oxidative stress. N Engl J Med 2002; 346: 1999-2001
15. Kitiyakara C, Chabrashvili T, Chen Y et al. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 2003; 14: 2775-2782
16. Kreutz R, Fernandez-Alfonso MS, Liu Y, Ganten D, Paul M. Induction of cardiac angiotensin I-converting enzyme with dietary NaCl-loading in genetically hypertensive and normotensive rats. J Mol Med 1995; 73: 243-248
17. Takeda Y, Yoneda T, Demura M, Miyamori I, Mabuchi H. Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. Endocrinology 2000; 141: 1901-1904
18. Kupari M, Koskinen P, Virolainen J. Correlates of left ventricular mass in a population sample aged 36 to 37 years. Focus on lifestyle and salt intake. Circulation 1994; 89: 1041-1050
19. Messerli FH, Schmieder RE, Weir MR. Salt. A perpetrator of hypertensive target organ disease?. Arch Intern Med 1997; 157: 2449-2452
20. du Cailar G, Mimran A. [Sodium and left ventricular hypertrophy in patients with hypertension]. Arch Mal Coeur Vaiss 1995; 88 Spec No 2: 15-19
21. du Cailar G, Gallay P, Ribstein J, Daures JP, Grolleau R, Mimran A. [Myocardial morphological changes related to sodium intake in normotensive and hypertensive patients never treated before]. Arch Mal Coeur Vaiss 1990; 83: 2045-2049
22. Tuomilehto J, Jousilahti P, Rastenyte D et al. Urinary sodium excretion and cardiovascular mortality in Finland: A prospective study. Lancet 2001; 357: 848-851
23. He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. J Am Med Assoc 1999; 282: 2027-2034
24. Volhard F, Fahr T. Die Bright'sche Nierenkrankheit. Julius Springer Verlag, Berlin; 1914
25. Mishra SI, Jones-Burton C, Fink JC, Brown J, Bakris GL, Weir MR. Does dietary salt increase the risk for progression of kidney disease?. Curr Hypertens Rep 2005; 7: 385-391
26. Ritz E, Schwenger V. Lifestyle modification and progressive renal failure. Nephrology (Carlton) 2005; 10: 387-392
27. Weir MR, Fink JC. Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? A commentary. Am J Kidney Dis 2005; 45: 176-188
28. Verhave JC, Hillege HL, Burgerhof JG et al. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 2004; 256: 324-330
29. Swift PA, Markandu ND, Sagnella GA, He FJ, MacGregor GA. Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: A randomized control trial. Hypertension 2005; 46: 308-312
30. Holler C, Abrahamian H, Auinger M. [Effect of nutrition on microalbuminuria in patients with type 1 diabetes: Prospective data evaluation over 5 years]. Acta Med Austriaca 1999; 26: 168-172
31. Benstein JA, Feiner HD, Parker M, Dworkin LD. Superiority of salt restriction over diuretics in reducing renal hypertrophy and injury in uninephrectomized SHR. Am J Physiol 1990; 258: F1675-F1681
32. Lax DS, Benstein JA, Tolbert E, Dworkin LD. Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys. Kidney Int 1992; 41: 1527 1534
33. Suzuki H, Yamamoto T, Ikegaya N, Hishida A. Dietary salt intake modulates progression of antithymocyte serum nephritis through alteration of glomerular angiotensin II receptor expression. Am J Physiol 2004; 286: F267-F277
34. Sanders PW. Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension 2004; 43: 142-146
35. Sanders MW, Fazzi GE, Janssen GM, Blanco CE, De Mey JG. High sodium intake increases blood pressure and alters renal function in intrauterine growth-retarded rats. Hypertension 2005; 46: 71-75
36. Denton D. The Hunger for Salt. Springer Verlag, Berlin; 1984
37. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991; 324: 1098-1104
38. Ivanovski O, Szumilak D, Nguyen-Khoa T et al. Dietary salt restriction accelerates atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 2005; 180: 271-276
39. Battista MC, Oligny LL, St-Louis J, Brochu M. Intrauterine growth restriction in rats is associated with hypertension and renal dysfunction in adulthood. Am J Physiol 2002; 283: E124-E131
40. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med 2003; 348: 101-108
41. Painter RC, Roseboom TJ, van Montfrans GA et al. Microalbuminuria in adults after prenatal exposure to the dutch famine. J Am Soc Nephrol 2005; 16: 189-194
42. ESH-ESC. 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the management of hypertension. J Hypertens 2003; 21: 1011-1053